{
  "actions": [
    {
      "acted_at": "1996-09-19", 
      "committee": "House Committee on Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "1996-09-25", 
      "in_committee": "House Committee on Commerce", 
      "references": [], 
      "subcommittee": "Health and Environment", 
      "text": "Referred to the Subcommittee on Health and Environment.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hres527-104", 
  "bill_type": "hres", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health and Environment", 
      "subcommittee_id": "04"
    }
  ], 
  "congress": "104", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1996-09-19", 
  "number": "527", 
  "official_title": "Relating to breast implants, the Food and Drug Administration, and public health.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": null, 
  "sponsor": {
    "district": "2", 
    "name": "McIntosh, David M.", 
    "state": "IN", 
    "thomas_id": "00776", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1996-09-19", 
  "subjects": [
    "Artificial implants", 
    "Autoimmune diseases", 
    "Breast cancer", 
    "Clinical trials", 
    "Commerce", 
    "Education", 
    "Educational policy", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Health education", 
    "Joint diseases", 
    "Medical research", 
    "Product safety", 
    "Science, technology, communications", 
    "Women", 
    "Women's health"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "1996-09-19", 
    "text": "Expresses the sense of the House of Representatives that the Food and Drug Administration should: (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Relating to breast implants, the Food and Drug Administration, and public health.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:33:36-05:00"
}